Brain Trauma Foundation
The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Use of barbiturates in the control of intracranial hypertension
Abstract
High-dose barbiturate therapy is efficacious in lowering ICP and decreasing mortality in the setting of uncontrollable ICP refractory to all other conventional medical and surgical ICP-lowering treatments. Utilization of barbiturates for the prophylactic treatment of ICP is not indicated. The potential complications attendant on this form of therapy mandate that its use be limited to critical care providers and that appropriate systemic monitoring be undertaken to avoid or treat any hemodynamic instability. When barbiturate coma is utilized, consideration should also be given to monitoring arteriovenous oxygen saturation as some patients treated in this fashion may develop oligemic cerebral hypoxia.
Source and rights
Published by Journal of neurotrauma, 2000. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- Brain Trauma Foundation
- Published
- 2000
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Journal of neurotrauma
- PubMed
- 10937896
More in critical care and anaesthesia
- Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) GuidelinesAmerican Society of Interventional Pain Physicians (ASIPP) · 2026
- Guidelines on Preventing Medication Errors in Anaesthesia and Intensive CareFrench Society of Anaesthesia and Intensive Care (SFAR : Société Française d'Anesthésie Réanimation) · 2026
